Alachua bio-tech company Brammer Bio, which provides gene therapies based on technology spun out of the University of Florida, is being sold for $1.7 billion to laboratory equipment provider Thermo Fisher Scientific.
Brammer Bio’s operation in Florida will remain intact, according to Brammer Bio and Thermo Fisher officials.
Brammer Bio manufactures viruses containing genetic material that has the potential to address and potentially cure inherited and acquired diseases. The company has nearly 600 employees at its primary locations in Alachua and Massachusetts. Thermo Fisher has revenues of more than $24 billion and about 70,000 employees.